AgomAb Therapeutics NV (AGMB) insider trading
AgomAb Therapeutics NV insiders have made 5 open-market purchases worth $400k since Oct 7, 2026, by 3 different insiders. The latest: David R. Epstein (Director) bought $89k, filed Oct 22, 2026, scored 40 out of 100. The biggest: $94k by Tim Jasper Knotnerus, filed Oct 7, 2026. 3 buys in the last year came within ten days of another insider's: a cluster, one of the stronger patterns in the research.
Follow AGMB, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Insider purchases
| Filed | Insider | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 22 Form 4 (opens sec.gov) |
David R. EpsteinDirectorDirector · Near 52-week low | +67% stake | 40 | $89k 10,000 at $8.88 |
−14.1% | waiting |
| Oct 9 Form 4 (opens sec.gov) |
David R. EpsteinDirector · 3 insiders buyingDirector · 3 insiders buying · Near 52-week low | +50% stake | 62 | $45k 5,000 at $8.90 |
−8.8% | waiting |
| Oct 7 Form 4 (opens sec.gov) |
David R. EpsteinDirectorDirector · 3 insiders buying · Near 52-week low | New position | 62 | $86k 10,000 at $8.63 |
−1.3% | waiting |
| Oct 7 Form 4 (opens sec.gov) |
Pierre Thadee Victor KemulaCFO · 2 insiders buyingCFO · 3 insiders buying · Near 52-week low | New position | 76 | $86k 10,000 at $8.59 |
−1.3% | waiting |
| Oct 7 Form 4 (opens sec.gov) |
Tim Jasper KnotnerusCEO · 3 insiders buyingCEO · 3 insiders buying · Near 52-week low | +102% stake | 72 | $94k 11,000 at $8.58 |
−1.3% | waiting |
Track record (hypothetical): a week after the filing, these buys averaged −5.3% (0% up, 5 measured).
Insiders who bought AGMB
- David R. Epstein Director
- Pierre Thadee Victor Kemula CFO
- Tim Jasper Knotnerus CEO
Questions
Are insiders buying AGMB stock?
Yes. In the last 90 days, 5 open-market purchases were filed, worth $400k.
Who bought AGMB stock most recently?
David R. Epstein, Director, bought 10,000 shares for $89k (Form 4 (opens sec.gov), filed Oct 22, 2026).
How does InsiderBeacon score an insider buy?
Out of 100, from who bought, how much their stake grew, the size of the trade, whether other insiders bought within ten days, where the price sat in its 52-week range, and whether it was a first or a routine buy. The score is fixed when the filing arrives. The formula and the research behind it.
Insiders are also buying, same industry
Data as of Oct 22, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer